Study on the strategy of the U.S.bilateral anti-malaria development assistance for health to Africa and implications
10.3969/j.issn.1674-2982.2024.04.009
- VernacularTitle:美国对非双边抗疟卫生发展援助策略研究及启示
- Author:
Jun-Yi SHI
1
;
Yi-Kai FENG
;
Yin-Zi JIN
;
Ming-Hui REN
Author Information
1. 北京大学公共卫生学院 北京 100191
- Keywords:
Development assistance for health;
Malaria prevention and control;
Sub-Saharan Africa
- From:
Chinese Journal of Health Policy
2024;17(4):58-64
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the characteristics of the U.S.bilateral anti-malaria development assistance for health(DAH)to Africa,and to provide suggestions for the future strategy of China's anti-malaria DAH.Methods:Policy analysis and descriptive statistical analysis were used to summarize the characteristics of the U.S.President's Malaria Initiative(PMI)in terms of funding input,program design,and monitoring and evaluation.Results:PMI had provided $8.62 billion to 24 African countries up to fiscal year 2022.Its assistance followed the framework of"prevention-case management-surveillance-behavioral interventions-health system capacity building",with more than 80%of total funding flowing to prevention and case management.In recent years,there has been increased support for surveillance and health system capacity building.The monitoring and evaluation included performance management and implement research.Conclusions and Suggestions:Characteristics of the U.S.bilateral anti-malaria DAH to Africa include:strong political commitment and high investment;program design that is consistent with international guidelines and integrated with its own advantages,and an emphasis on results-oriented evaluation and feedback learning.In the future,China should increase resource input to implement the political commitments,develop strategies for anti-malaria DAH based on national guidelines and domestic experience,and conduct project surveillance and evaluation.
